Pharma Journalist -

Bristol-Myers Squibb Company and QIAGEN have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as…
Read More...

Sanofi and Regeneron Pharmaceuticals announced positive preliminary results with investigational REGN2810, a checkpoint inhibitor targeting PD-1 (programmed death 1), in patients with…
Read More...

Braeburn Pharmaceuticals announced that Michael M. Derkacz has been named as President and Chief Executive Officer and joins Braeburn's Board of Directors. A biopharmaceutical executive…
Read More...

ESSA Pharma, a clinical-stage pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, announced that early data from the…
Read More...

Kamada, a plasma-derived protein therapeutics company focused on orphan indications, announced the appointment of Michal Stein, M.D., as Vice President and Medical Director for…
Read More...

BioCryst Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for a pediatric indication of…
Read More...

Cornerstone Pharmaceuticals announced that it is changing its corporate name to Rafael Pharmaceuticals effective immediately. The name change signifies a new era in the company’s…
Read More...

Aequus Pharmaceuticals and the Centre For Drug Research and Development (CDRD) announced a broad research collaboration to establish pre-clinical safety and efficacy of select…
Read More...

Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review its recently submitted New Drug Application (NDA) for  …
Read More...

The pharmaceutical Company Sylentis (PharmaMar Group) has announced the start of the first Phase III study, HELIX, with the investigational new drug, SYL1001 for the indication of dry…
Read More...